The market for private company shares has quickly evolved from opaque, relationship‑driven networks into a structured ecosystem. Accredited investors can now access late‑stage pre‑IPO companies through platforms which provide vital liquidity. Navigating these marketplaces requires understanding their distinct fee models, verification processes, and valuation methods. This updated August 2026 guide reviews five prominent platforms defining the secondary market landscape.
1. Forge Global
Pricing/fee structure: Fees and minimums undisclosed; account access required. Transparency via proprietary “Forge Price™” and live order books pre-trade.
Accredited investor requirements and verification: Mandatory. Earned income >$200k ($300k joint) with reasonable expectation of maintenance or net worth >$1M (excluding residence). Or active FINRA Series 7, 65, or 82 license.
Liquidity events: Secondary trading alongside tender offers and IPOs and SPVs. Employee/shareholder liquidity via broker-matched transactions and institutional deal flow.
Valuation methodology: Proprietary “Forge Price™” derived daily from secondary transactions, IOIs, and primary funding. Distinct from static last-round/409A; post-money valuations via company-submitted COIs.
Use cases: Employee liquidity, fund rebalancing, and pre-IPO exposure. Can also be used for family office concentration management and wealth manager portfolio enhancement.
Cerebras-specific: Forge tracks Cerebras in its Private Market Index and Thematic Baskets, recording a ~$113.50 final price, $2.92B total funding, and $22.91B Series H valuation. The analysis highlights wafer‑scale processors, OpenAI/AWS partnerships, and Nvidia‑challenging positioning ahead of its May 14, 2026 NASDAQ debut (CBRS; $185/share, $5.55B raised at ~$56.43B implied valuation).
Regulatory/compliance: Forge Securities LLC (FINRA/SIPC) and RIA Forge Global Advisors LLC. SEC/Reg D compliant. Form CRS provided; no legal/tax advice.
Transaction process/timeline: Register → Verify → Bid → IOI → Negotiate → Execute → Close. Real-time order book included. Settlement varies; closing may lag agreements by weeks.
Pros
- Proprietary Forge Price™ provides daily pricing based on actual secondary activity vs. stale rounds.
- Institutional infrastructure via Charles Schwab’s Alternative Investments Select platform with >$5M in assets.
Cons
- Opaque fees/minimums require registration to determine costs.
- Illiquid securities with no guaranteed market; Forge Price is indicative only.
2. Hiive
Pricing/fee structure: $25K minimum for direct trades. Fixed seller fees; schedules unlisted. Funds charge no management/carry, only transaction/admin fees.
Accredited investor requirements and verification: Mandatory SEC accreditation. KYC/AML/suitability checks required. Unavailable to unaccredited investors.
Liquidity events: Secondary trading and tender offers alongside buybacks and block trades and single-asset funds. Issuer pre-approval required.
Valuation methodology: Live order book with hourly updates. References last-round, 409A, comps, secondary data. Hiive Price™ blends transactions/bid-ask midpoints. Hiive50 Index tracks top 50 liquid names.
Use cases: Employee liquidity; VC secondaries; institutional/UHNW pre-IPO exposure; issuer cap table management via batched transfers.
Cerebras-specific: Hiive’s Cerebras Systems liquidity report documented 712+ pre-IPO transactions and a final Hiive Price of $141.11 (+913%) alongside a $23B Series H valuation, emphasizing the WSE-3 chip, $10B OpenAI deal, and Nvidia competition prior to its May 14, 2026 NASDAQ debut (CBRS; opened $350, closed $311.07).
Regulatory/compliance: Hiive Markets Limited (FINRA/SIPC; Canadian EMD). Reg D exempt. Form CRS required. Issuer consent/ROFR enforced.
Transaction process/timeline: Anonymous bidding → direct negotiation → issuer approval → standardized closing (~30 days for funds). Direct counterparty access reduces friction.
Pros
- Real-time price discovery across 3,000+ companies with $300M+ monthly volume, updated August 2026.
- Issuer-aligned framework with pre-approved windows streamlines consent.
Cons
- Issuer ROFR can block/delay agreed transactions.
- Information asymmetry persists due to limited private disclosure.
3. EquityZen
Pricing/fee structure: Fees/minimums undisclosed; sign-up required. Single/Multi-Company Funds and Direct Acquisitions available. Historical avg net PPS includes platform costs (e.g., Cerebras $32.94).
Accredited investor requirements and verification: Mandatory SEC accreditation. KYC/BSA/OFAC checks via proprietary tech.
Liquidity events: SPV funds (Standard/Express) and direct brokered transactions. Liquidity upon IPO/acquisition/tender. Funds act as single passive shareholders.
Valuation methodology: Primarily last-round pricing and proprietary “Market Score.” Equity Value Tool for sellers. Lacks real-time bid/ask order books.
Use cases: Employee liquidity/diversification; early investor rebalancing; low-minimum fund access; wealth manager alternatives; company-approved retention liquidity.
Cerebras-specific: EquityZen’s Cerebras analysis reported 5.62x IPO returns on a $32.94 average net PPS and $23B Series H valuation, citing Fidelity (9.3%) and Benchmark (8.0%) as major holders, and highlighting its wafer‑scale AI architecture and Nvidia‑challenging positioning ahead of the May 14, 2026 NASDAQ debut (CBRS; $185/share, $40.64B valuation).
Regulatory/compliance: EquityZen Securities LLC (SEC/FINRA/SIPC; Morgan Stanley subsidiary). Reg D exempt. Internal tickers only. Issuer approval required.
Transaction process/timeline: Investor: Verify → Reserve → Fund → Exit. Seller: Pricing → Demand → Approval → Close. Coordinates escrow/legal; timeline varies by issuer.
Pros
- Morgan Stanley backing and 55,000+ approved transactions with $1.5B+ distributed to shareholders provide institutional credibility.
- SPV structure simplifies cap tables and lowers access barriers vs. direct purchases.
Cons
- Opaque fees require account creation; displayed prices may not reflect net economics.
- No real-time order book. Valuations rely heavily on stale last-round data.
4. Nasdaq Private Market (NPM)
Pricing/fee structure: Typical $25K minimum. Fees split equitably between buyers/sellers and published in-platform; lower than high single-digit seller fees. NPM Funds have separate terms.
Accredited investor requirements and verification: Buyers must be SEC accredited. Sellers need not be. Institutions require QIB/accredited entity status.
Liquidity events: Tender offers, buybacks, auctions, trading windows, block trades, single-asset funds, primary raises.
Valuation methodology: Proprietary “NPM Price” uses six signals: secondary trades, bid/ask, primary PPS, 409A, mutual fund marks, source docs. Reflects actual transaction data. Waterfall modeling available.
Use cases: Employee liquidity; institutional deal flow; company liquidity programs; bank settlement licensing; wealth manager integration.
Cerebras-specific: NPM tracked a pre-IPO price estimate of $118.11 alongside Series H ($1B, Feb 2026) and Series G ($1.1B, Sep 2025) funding history, noting AI deep learning systems and Nvidia-competitive positioning; a testimonial from Cerebras’ VP confirmed NPM’s patented settlement streamlined secondary transactions prior to its May 14, 2026 NASDAQ debut (CBRS).
Regulatory/compliance: NPM Securities LLC (FINRA/SIPC) and SecondMarket Financial LLC (SEC RIA). SOC 2 certified ATS. Provides patented settlement. Issuer approval required.
Transaction process/timeline: Account → Browse → Bid/Negotiate → Settle via patented tech. Avg 30–60 days; patented engine and claims ~12 days faster than off-platform. Automated STN/ROFR/docs.
Pros
- Patented settlement reduces timelines by avg 12 days with automated ROFR/docs.
- Nasdaq-backed infrastructure with >$45B facilitated liquidity and global buyer network.
Cons
- Specific fee percentages undisclosed publicly; must access platform for exact costs.
- Post-IPO tracking ceases immediately, limiting longitudinal analysis.
5. Caplight
Pricing/fee structure: Undisclosed; “Book a demo”/institutional inquiry basis. Securities via Caplight Markets LLC (FINRA/SIPC). Retail pricing unavailable.
Accredited investor requirements and verification: Designed for institutions/VCs. Employees can access pricing/matching, but executing trades requires vetted brokers and buyer accreditation.
Liquidity events: Secondary trading via live order book ($5.2B+ interest), broker matching, tender tracking. Employee liquidity via broker network.
Valuation methodology: Proprietary “MarketPrice™” (U.S. Patent No. 12,243,130) uses funding, trades, bids/asks, fund marks. Filters opportunistic bids; adjusts for SPV fees. Covers 180+ companies.
Use cases: Institutional sourcing/marking; secondary blocks; VC monitoring; employee pricing/liquidity; API data for wealth managers. Agentic sourcing via MCP.
Cerebras-specific: Not Available. While Caplight tracks 60,000+ companies and likely includes Cerebras in its MarketPrice™ dataset, the provided source contains no dedicated profile, research report, or specific pricing/funding data for Cerebras comparable to other platforms’ coverage.
Regulatory/compliance: Caplight Markets LLC (FINRA/SIPC). Patented pricing. No tax/legal advice; offerings subject to final docs.
Transaction process/timeline: Institutional: Demo → Order book → Connect → Negotiate → Execute. Employee: Import → Price → Broker match → Execute. Emphasizes instant connectivity.
Pros
- Patented MarketPrice™ filters noise/SPV fees for institutional-grade pricing ($300B+ data).
- Largest institutional network (700+ participants, $5B+ daily interest) enables superior liquidity discovery.
Cons
- Institutional-only access excludes individual accredited investors without broker intermediation.
- Post-IPO tracking ceases immediately, limiting longitudinal analysis.
Summary Comparison Table
| Company | Pricing | Key features | Best for |
| Forge Global | Undisclosed | Forge Price™, live order books | Infrastructure |
| Hiive | $25K minimum | Real-time order book | Price discovery |
| EquityZen | Undisclosed | SPV structures | Lower minimums |
| Nasdaq Private Market | ~$25K minimum | Patented settlement | Fast execution |
| Caplight | Institutional | MarketPrice™, $5B+ interest | Institutions |
“Secondary markets provide liquidity, enable broad participation, and help preserve the value of securities as investors trade.” – Investopedia
Conclusion
The Problem
The private secondary market offers accredited investors access to high‑growth pre‑IPO companies but remains fragmented, with opaque fees, inconsistent valuations, and uneven liquidity. Pricing can diverge sharply across platforms (e.g., Cerebras Systems ranged from $113.50 on Forge to $141.11 on Hiive). Execution risks stem from issuer approvals, ROFR provisions, and settlement delays, while SEC accreditation and KYC/AML add friction. Most critically, regulation lags behind the market’s rapid evolution, leaving investors to navigate complex SPVs, tax issues, and post‑IPO risks without standardized guidance.
Key Takeaways
- Valuation methodologies vary widely: Platforms like Hiive and Forge utilize dynamic, transaction-based indices and live order books. But others rely more heavily on traditional last-round pricing.
- Issuer consent is critical: Most private share transactions require company approval or are subject to ROFR, meaning deals can face friction or delays despite agreement.
- Target audience segmentation: Platforms cater differently to distinct user bases. Some offer approachable entry points for individuals, others focus strictly on institutions and some like Hiive cater to both individuals and institutions.
Next Steps
- Verify status: Confirm accredited investor eligibility. Then prepare documentation to streamline SEC and KYC/AML checks.
- Define strategy: Decide between single‑company exposure or multi‑company funds (SPVs). Clarify whether your goal is liquidity (diversifying employee stock) or growth (pre‑IPO access).
- Register and compare fees: Open accounts to review schedules and assets. Request written disclosures and minimums from Forge, EquityZen, and Caplight, then benchmark against Hiive and NPM published split models to assess true all‑in cost.
Frequently Asked Questions
What constitutes an accredited investor?
Individuals with an annual income exceeding $200k ($300k joint), a net worth over $1M excluding primary residence, or active FINRA Series 7, 65, or 82 licenses.
Can I sell private shares before an IPO?
Most platforms require holding the asset until an IPO, acquisition, or tender offer occurs, but some allow secondary listings subject to issuer approval.
What happens when a company goes public?
Once the post-IPO lock-up period expires, private shares convert into standard common stock tradable on public exchanges.